Evidence map›Paper›PMID 31418583›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2019

Exosomes derived from induced vascular progenitor cells promote angiogenesis in vitro and in an in vivo rat hindlimb ischemia model.

Takerra K Johnson, Lina Zhao, Dihan Zhu, Yang Wang, Yan Xiao, Babayewa Oguljahan, Xueying Zhao, Ward G Kirlin, Liya Yin, William M Chilian and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Is miR-21 A Therapeutic Target in Cardiovascular Disease?International journal of drug discovery and pharmacology · 2023
    Article
  14. Exosomes for angiogenesis induction in ischemic disorders.Journal of cellular and molecular medicine · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Takerra K JohnsonCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Lina ZhaoCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Dihan ZhuCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Yang WangCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Yan XiaoCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Babayewa OguljahanCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Xueying ZhaoDepartment of Physiology, Morehouse School of Medicine, Atlanta, Georgia.
Ward G KirlinDepartment of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, Georgia.
Liya YinDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio.ORCID 0000-0001-7825-9539
William M ChilianDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio.
Dong LiuCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia.
Morehouse School of Medicine · USNortheast Ohio Medical University · US

Funding

TISSUE CULTURE MODEL FOR RETINITIS PIGMENTOSA--A MOLECULAR APPROACHR25GM058268 · NIGMS · MOREHOUSE SCHOOL OF MEDICINE · PI HARRIS-HOOKER, SANDRA, STILES, JONATHAN K. · 1998 to 2023
$16.5M
Morehouse Cardiovascular Research Center of ExcellenceP50HL117929 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI TAYLOR, HERMAN ALFRED · 2013 to 2018
$6.7M
Mechanisms of Impaired Coronary Collateral GrowthR01HL137008 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI YIN, LIYA · 2018 to 2021
$1.6M
Microvesicles from Adipose-derived Stem Cells for Ischemic Heart RepairSC1HL134212 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI LIU, DONG · 2016 to 2019
$1.4M
Proangiogenic microRNA in Microvesicles Released from Adipose-derived Stem CellsSC2GM099629 · NIGMS · MOREHOUSE SCHOOL OF MEDICINE · PI LIU, DONG · 2012 to 2014
$420k
NHLBI NIH HHS P50 HL117929NHLBI NIH HHS R01 HL137008NHLBI NIH HHS SC1 HL134212NIGMS NIH HHS R25 GM058268NIGMS NIH HHS SC2 GM099629
6 · The paper itself

Abstract

Induced vascular progenitor cells (iVPCs) were created as an ideal cell type for regenerative medicine and have been reported to positively promote collateral blood flow and improve cardiac function in a rat model of myocardial ischemia. Exosomes have emerged as a novel biomedicine that mimics the function of the donor cells. We investigated the angiogenic activity of exosomes from iPVCs (iVPC-Exo) as a cell-free therapeutic approach for ischemia. Exosomes from iVPCs and rat aortic endothelial cells (RAECs) were isolated using a combination of ultrafiltration and size-exclusion chromatography. Nanoparticle tracking analysis revealed that exosome isolates fell within the exosomal diameter (<150 nm). These exosomes contained known markers Alix and TSG101, and their morphology was validated using transmission electron microscopy. When compared with RAECs, iVPCs significantly increased the secretion of exosomes. Cardiac microvascular endothelial cells and aortic ring explants were pretreated with RAEC-Exo or iVPC-Exo, and basal medium was used as a control. iVPC-Exo exerted an in vitro angiogenic effect on the proliferation, tube formation, and migration of endothelial cells and stimulated microvessel sprouting in an ex vivo aortic ring assay. Additionally, iVPC-Exo increased blood perfusion in a hindlimb ischemia model. Proangiogenic proteins (pentraxin-3 and insulin-like growth factor-binding protein-3) and microRNAs (-143-3p, -291b, and -20b-5p) were found to be enriched in iVPC-Exo, which may mediate iVPC-Exo induced vascular growth. Our findings demonstrate that treatment with iVPC-Exo promotes angiogenesis in vitro, ex vivo, and in vivo. Collectively, these findings indicate a novel cell-free approach for therapeutic angiogenesis.

Indexed as

Neovascularization, PhysiologicAngiogenic ProteinsAnimalsCell LineCell MovementCell ProliferationCytokinesDisease Models, AnimalEndothelial Progenitor CellsExosomesHindlimbInduced Pluripotent Stem CellsIschemiaMaleMicroRNAsMuscle, SkeletalAngiogenic ProteinsCytokinesMicroRNAsangiogenesisendothelial cellexosomesmicroRNAprogenitor cell

Identifiers

PMID31418583
PMCPMC6843021
OpenAlexW2967781119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.